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of the extracellular matrix ( 1, 2 ). In the arterial intima, 
the retained LDL particles become modifi ed and can ag-
gregate ( 3 ). Aggregation of LDL particles increases their 
binding strength to the proteoglycans and in this way may 
enhance the extracellular retention of LDL in the arterial 
intima ( 3, 4 ). SMase, which catalyzes the hydrolysis of sphin-
gomyelin into phosphorylcholine and ceramide, is sug-
gested to be one of the key enzymes responsible for LDL 
aggregation during atherogenesis ( 3 ). Indeed, in aggregated 
LDL isolated from human atherosclerotic lesions, the cer-
amide content is 10–50-fold higher than in corresponding 
plasma LDL, and treatment of LDL with human recombi-
nant secretory SMase (hrSMase) in vitro induces the forma-
tion of lesion-like LDL aggregates ( 5 ). More recently, a causal 
role for secretory SMase in the development of athero-
sclerotic lesions was shown in vivo: a defi ciency of acid 
SMase was associated with a reduction of lipoprotein re-
tention and atherosclerotic lesions in mice ( 6 ). 
 Macrophages and endothelial cells secrete SMase in 
vitro ( 7 ). Immunoreactive secretory SMase is found in hu-
man atherosclerotic lesions, where it is mostly associated with 
the extracellular matrix ( 8 ). The secretory SMase has an 
acidic pH optimum and is able to hydrolyze LDL at neutral 
pH only if the LDL particles have been premodifi ed, e.g., by 
phospholipase A 2 , oxidative agents, or by proteolytic enzymes 
( 9, 10 ). All these modifi cations lead to changes in the surface 
structure of the LDL particles. Analogously, we may infer that 
premodifi cation of the surface structure of LDL particles is 
necessary for the ability of the secretory SMase to attack LDL 
particles at neutral pH. Thus, when present in the superfi cial 
layer of atherosclerotic lesions, where the extracellular pH 
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 Bacterial SMase-treated LDL was prepared by incubating LDL 
(1.25 mg/ml) in Dulbecco’s PBS (BioWhittaker; Verviers, Bel-
gium) containing 200 mU/ml of  Bacillus cereus SMase (bcSMase) 
(Sigma-Aldrich). After 30 min incubation, lipolysis was stopped 
by adding EDTA, to give a fi nal concentration of 10 mM. The 
degree of lipolysis was determined by a measurement of phos-
phorylcholine using a modifi cation of the Amplex Red SMase 
Assay Kit (Molecular Probes; Invitrogen, UK). 
 LDL particles were also modifi ed with hrSMase (a kind gift 
from Genzyme) by incubating LDL (1.0 mg/ml) with 20 µg/ml 
hrSMase in a buffer containing 150 mM NaCl and 50 µM ZnCl 2 in 
either 20 mM MES (pH 5.5 or pH 6.0), 20 mM PIPES (pH 6.5), or 
20 mM HEPES (pH 7.0 or 7.5) for the indicated times, at 37°C. 
 Preparation of lipid microemulsions from LDL lipids 
 Lipids were extracted from 5–10 mg of LDL by the method of 
Bligh and Dyer ( 22 ) and evaporated under N 2 .  
3 H-cholesteryl li-
noleate was added to the lipid mixtures for radiolabeling. Micro-
emulsion particles were prepared essentially as described by 
Ginsburg et al. ( 23 ), and the dried lipids were resuspended in 2 ml 
PBS and sonicated under N 2 at 50°C for 6 × 5 min using a Bran-
son Sonifi er 250 sonicator, followed by centrifugation for 5 min 
at 14,000  g . The amount of total cholesterol in the lipid particles 
was determined using a commercial kit (Roche; Indianapolis, IN). 
 Aggregation of LDL particles 
 Native or bcSMase-treated LDL particles (100 µl, 1 mg/ml) 
were incubated in a microtiter well plate in a buffer containing 
150 mM NaCl, and either 20 mM MES (pH 5.5 or 6.0), 20 mM 
PIPES (pH 6.5 or 7.0), or 20 mM HEPES (pH 7.5). In some ex-
periments, LDL was proteolyzed with   -chymotrypsin (Sigma-
Aldrich) or pronase E (Sigma-Aldrich) either before or after 
bcSMase treatment ( 10 ). In addition, in some experiments, the 
incubation mixture contained monoclonal antibodies (Bsol 2, Bsol 
14: 0.36 mg/ml). Aggregation of the LDL samples was followed 
by measuring the absorbance of the LDL samples at 405 nm. The 
sizes of the aggregated particles were determined by asymmetri-
cal fl ow-fi eld-fl ow fractionation (AsFlFFF) as described ( 24 ) or by 
dynamic light scattering (DLS) (Zetasizer Nano, Malvern). 
 Aggregation of LDL particles with lipid microemulsions 
 35 S-radiolabeled LDL particles and  3 H-radiolabeled lipid micro-
emulsions, either unmodifi ed or bcSMase-modifi ed, were incu-
bated together in the pH buffers as described above. After the 
incubation, the amounts of aggregated LDL particles and micro-
emulsions were determined by separating the large aggregates by 
centrifugation at 15,000  g for 15 min. After centrifugation, the 
supernatants and the sedimented particles were collected sepa-
rately and their radioactivities were measured. 
 Circular dichroism analyses 
 Circular dichroism (CD) analysis of LDL samples was per-
formed using 50   g/ml LDL, native or bcSMase-modifi ed. CD 
spectra were recorded on a JASCO J-715 spectropolarimeter 
(Japan Spectroscopic Co.; Tokyo, Japan) using a 0.1 cm quartz 
cuvette in the region of 190–250 nm with a step size of 0.5 nm, 
scan speed of 50 nm per min, band width of 1 nm, and 1 s re-
sponse. The cell holder compartment was thermostatically 
maintained at 37 ± 0.1°C. Five spectra for each sample were 
averaged, and blank measurements were subtracted. 
 RESULTS 
 LDL was treated with hSMase at pH values 5.5–7.5. 
For this purpose, LDL was incubated in MES-, PIPES-, or 
is neutral, secretory SMase is likely to act on LDL only after 
the particles have been premodifi ed by the other agents 
capable of modifying LDL at this pH. 
 The arterial intima is an avascular tissue, and oxygen can 
reach the intima only by diffusion from the lumen or from 
the medial layer of the arterial wall. The diffusion distance of 
oxygen in tissues is only about 200 µm ( 11 ), and hypoxic ar-
eas develop in the lesions already at this depth ( 12, 13 ). Even 
the normal arterial intima of atherosclerosis-prone sites in 
humans exceeds this critical diffusion distance of oxygen, 
and during atherogenesis, the thickness of the intima may 
increase to more than 3,000 µm ( 12 ). Under hypoxia, cells 
switch to anaerobic metabolism, which leads to the produc-
tion of lactate and thus the secretion of excess H + ions. 
Indeed, increased extracellular lactate concentrations are 
found particularly in the hypoxic areas of atherosclerotic 
lesions ( 14 ). Also, decreased extracellular pH values have 
been determined ( 15 ). Thus, already at a distance of 200 µm 
from the lumen, pH values as low as 6.8 have been measured, 
and visualization of human carotid plaques with pH-sensitive 
fl uorescent dyes has indicated that the pH may reach values 
which are even below pH 6.0. A recent report indicates that 
macrophages generate pericellular pH gradients, with their 
lowest values reaching 5.0 ( 16 ). In addition, the acidity of the 
extracellular fl uid may be increased in the vicinity of the sul-
fate and carboxylic acid groups of proteoglycan side chains. 
Interestingly, accumulation of lipids in the atherosclerotic 
lesions begins in the deep areas of the diffuse intimal thick-
ening of arterial intima ( 17 ), where the pH is more acidic 
than in the superfi cial intima. In the acidic areas of the 
atherosclerotic lesions, secretory SMase is located in an ex-
tracellular milieu with an optimal pH. 
 In the present study, we examined the effect of pH on 
SMase-induced LDL aggregation. The lower the pH, the 
higher was the degree of aggregation and the larger were 
the aggregates formed. Thus, when LDL particles iden-
tically lipolyzed with bacterial SMase were incubated at 
acidic pH, micron-sized LDL aggregates were formed, 
while aggregates formed at neutral pH had sizes averaging 
100–200 nm. SMase-induced LDL aggregation was found 
to be mediated by apoB-100 and required conformational 
changes in the secondary structure of the apolipoprotein. 
 EXPERIMENTAL PROCEDURES 
 Isolation and modifi cations of LDL 
 Human LDL ( d = 1.019–1.050 g/ml) and HDL 3 ( d = 1.125–
1.210 g/ml) were isolated from the plasma of healthy volun-
teers (Finnish Red Cross) by sequential ultracentrifugation in 
the presence of 3 mM EDTA ( 18, 19 ). The amounts of LDL 
were expressed in terms of their protein concentrations, which 
were determined by the method of Lowry et al. ( 20 ), with BSA 
as the standard. Each experiment was performed with LDL 
from at least two donors.  3 H- and  35 S-radiolabeled LDL was 
prepared by labeling the protein component of LDL by the 
procedure of Bolton and Hunter ( 21 ), with  3 H-labeling reagent 
( t -buto xycarbonyl- L -[ 3 H]methionine  N -hydroxy-succinimidyl 
ester [Amersham Biosciences]) or with  35 S-labeling reagent 
( t -butoxycar bonyl- L -[ 35 S]methionine  N -hydroxysuccinimidyl ester 
[Amersham Biosciences]). 
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AsFlFFF, a method that has been used to determine the 
sizes of modifi ed LDL particles ( 24 ). We fi rst treated the 
lipid microemulsions with bcSMase at neutral pH, stopped 
the activity of the enzyme, and divided the bcSMase-treated 
lipid microemulsions into two aliquots, whose pH was ad-
justed to 5.5 or 7.5. About 75% of the sphingomyelin mol-
ecules in the particles were lipolyzed. After incubation for 
24 h, the sizes of the lipid particles were determined. The 
bcSMase-treatment only slightly increased the average size 
of the lipid microemulsions from 85 nm (unmodifi ed mi-
croemulsions) to about 110 nm at both pH 5.5 and 7.5 
 ( Fig. 2A ). Thus, in striking contrast to the SMase-treated 
LDL particles, the pH of the incubation mixture had no 
effect on the aggregation of LDL-derived lipid microemul-
sions. This fi nding indicates that the protein component 
of the LDL particles was necessary for the increased aggre-
gation of SMase-treated LDL at acidic pH. 
 Next, we performed an experiment to determine whether 
the SMase-treated particles can aggregate via interactions 
between the protein component of one particle and the lipid 
HEPES-buffered saline containing 50 µM ZnCl 2 with or 
without 20 µg/ml of hrSMase. Because the human enzyme 
has an acidic pH optimum, substantial hydrolysis of LDL 
was observed only at pH 6.0 and 5.5 (see supplementary 
Fig. IA). Similarly, substantial aggregation, measured as 
turbidity of the incubation mixtures, was observed only at 
these pH values (see supplementary Fig. IB). After incuba-
tion for 24 h, the actual sizes of LDL treated with hrSMase 
were determined with DLS. In accordance with the tur-
bidity data, LDL aggregates were found only at pH 6.0 
and 5.5, at which the average sizes of LDL aggregates were 
about 400 nm and 1,000 nm, respectively  ( Fig. 1A ). Of note, 
the size of LDL aggregates varies among different LDL 
donors. Typically, the size of LDL treated with hrSMase 
for 20 h at pH 5.5 varied between 600 and 5,000 nm. 
 Because the secretory SMase has an acidic pH optimum, 
the degrees of lipolysis in the above experiment were dif-
ferent. To examine the effect of pH on the aggregation 
process solely, LDL was fi rst treated for 30 min with bcS-
Mase at pH 7.5 to obtain an identical degree of lipolysis in 
all the samples. The use of bcSMase allowed us to use short 
incubation times for the lipolysis and so minimize particle 
aggregation during this initial phase. After the incubation, 
the activity of the enzyme was inhibited by the addition of 
EDTA. About 70% of LDL sphingomyelin was hydrolyzed 
under the conditions used here. The bcSMase-treated 
LDL was then divided into aliquots, the pH values of the 
aliquots were adjusted to 5.5, 6.0, 6.5, 7.0, or 7.5, and the 
samples were then incubated at the various pH values at 
37°C for the indicated times. At each time point, the tur-
bidity of the samples was determined as a measure of par-
ticle aggregation. As shown in supplementary Fig. II, the 
turbidity of each sample increased during the incubation, 
indicating progressive lipoprotein aggregation. The lower 
the pH of the incubation mixture, the higher the turbidity 
of the lipolyzed LDL samples, which indicates an increased 
tendency for aggregation at acidic pH values. Unmodifi ed 
LDL did not aggregate at any pH, as exemplifi ed by the 
extreme condition of pH 5.5 in the absence of bcSMase 
(see supplementary Fig. II). In accordance with the in-
creased turbidity, the size of the bcSMase-treated LDL par-
ticles progressively increased, and the lower the pH was, 
the larger were the generated aggregates ( Fig. 1B ). Thus, 
the average size of bcSMase-treated LDL aggregates was 
120 nm at pH 7.5, whereas it was 1,800 nm at pH 5.5. 
Again, the size of aggregates generated at pH 5.5 was 
found to vary signifi cantly among different donors. Typi-
cally, the size of LDL aggregates after an overnight incuba-
tion was below 300 nm at pH 6.5  7.5, 400–1,500 nm at pH 
6.0, and 500–5,000 nm at pH 5.5. 
 To examine the mechanisms by which the SMase-treated 
LDL particles aggregate, we next examined whether cer-
amide might induce aggregation more effi ciently at acidic 
pH. For this purpose, we used lipids extracted from LDL 
particles to generate lipid microemulsions devoid of any 
protein. Because the turbidity of microemulsions is rather 
high, turbidity measurements could not be performed to 
follow particle aggregation. Instead, to estimate the sizes of 
unmodifi ed and SMase-treated microemulsions, we applied 
 Fig.  1. Aggregation of SMase-treated LDL at different pH values. 
A: LDL was incubated in the presence of 20 µg/ml hrSMase for 21 h 
at the indicated pH values. After the incubation, the sizes of native 
LDL particles (black) and SMase-treated LDL particles (pH 7.5, 
purple; pH 7.0, light blue; pH 6.5, dark blue; pH 6.0, red; pH 5.5, 
green) were determined by DLS. Please note the logarithmic scale 
in the  x axis. B: LDL particles were treated with bcSMase for 
30 min, after which the lipolysis was stopped by adding EDTA. 
Next, the identically lipolyzed LDL particles were incubated at 
37°C at the indicated pH values, and at the indicated time points, 
particle size was determined by DLS. 
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microemulsions, so revealing an inhibitory effect of the emul-
sions on aggregation of bcSMase-treated LDL particles. 
 The above experiments indicate that at acidic pH, the 
lipid components of SMase-treated LDL particles are not 
responsible for LDL aggregation. Because many proteins are 
known to be prone to aggregation under acidic conditions, 
and, importantly, apoB-100 has been shown to be particularly 
susceptible to aggregation in various circumstances ( 25 ), we 
next explored the role of apoB-100 in SMase-induced aggre-
gation of LDL at acidic pH. Proteolytic degradation of LDL 
particles by proteases having broad substrate specifi city leads 
to release of peptide fragments from LDL. We reasoned 
that release of apoB-100 fragments could inhibit apoB-100-
mediated LDL aggregation and followed the changes in 
the sizes of three different bcSMase-treated LDL prepara-
tions:  1 ) bcSMase-LDL,  2 ) preproteolyzed bcSMase-LDL, 
and  3 ) bcSMase-LDL that was proteolyzed after the bcSMase-
treatment, i.e., postproteolyzed bcSMase-LDL. Thus, LDL 
was fi rst treated with   -chymotrypsin, after which bcSMase 
was used to fully lipolyze the preproteolyzed LDL (  -CT + 
SMase) and unproteolyzed LDL particles (SMase). A 
fraction of the bcSMase-treated particles was treated with 
  -chymotrypsin after lipolysis (SMase +   -CT). All particles 
were fully lipolyzed and the degree of proteolysis was simi-
lar in the pre- and postlipolyzed particles (20% and 21% 
of trichloroacetic acid-soluble peptide fragments were 
generated, respectively). Particle aggregation was then fol-
lowed at pH 5.5 by measuring the size of the particles. Pre-
proteolysis had no effect on LDL aggregation  ( Fig. 3A ). 
However, when the order of proteolysis and lipolysis was 
reversed, and LDL was fi rst treated with bcSMase and only 
then subjected to proteolysis, postproteolysis completely 
blocked particle aggregation ( Fig. 3A ). These fi ndings sug-
gest that the segments of apoB-100 that mediate aggrega-
tion of SMase-treated LDL particles are not accessible to 
proteolytic cleavage in unmodifi ed LDL particles, but are acces-
sible to such cleavage in SMase-treated particles. Thus, SMase 
treatment appears to lead to exposure of aggregation-
prone sites in apoB-100, and proteolytic cleavage of these 
sites can inhibit particle aggregation. 
 Next, the effect of SMase treatment on the conforma-
tion of apoB-100 was examined. LDL was treated with bcS-
Mase for 30 min, after which the secondary structure of 
apoB-100 was analyzed by CD. As shown in  Fig. 3B , acidifi -
cation alone did not have an effect on the conformation of 
apoB-100, but SMase treatment dramatically decreased 
the   -helix content of apoB-100, with an apparent con-
comitant increase in the   -strand content, as inferred from 
the large changes in the shapes of the curves. Importantly, 
the changes in the conformation of apoB-100 occurred be-
fore particle aggregation and were thus caused by the li-
polytic modifi cation alone. No further changes in apoB-100 
secondary structure occurred, when the particles were fur-
ther incubated for up to 1 h ( Fig. 3C ), at which point, par-
ticle aggregation is already in progress and the average 
size of the particles is typically 200–600 nm. 
 We have previously ( 26 ) shown that SMase-induced 
LDL aggregation at neutral pH does not occur below 
the transition temperature of LDL particles, which is 
component of another particle. For this purpose, nonlipo-
lyzed or bcSMase-treated  35 S-labeled LDL particles were in-
cubated with nonlipolyzed or bcSMase-treated  3 H-labeled 
lipid microemulsions in various combinations. After 20 h, 
the mixtures were centrifuged to sediment any large aggre-
gated particles. Using  35 S-labeled LDL and  3 H-labeled lipid 
microemulsions, we could determine the amounts of LDL 
particles and lipid microemulsions in the sedimented ag-
gregates. As shown in  Fig. 2B , bcSMase-treated lipid micro-
emulsions aggregated neither spontaneously nor after 
incubation with nonlipolyzed or bcSMase-treated LDL. In 
fact, the lipid microemulsions prevented the aggregation of 
bcSMase-treated LDL particles. Thus, the bcSMase-treated 
LDL particles aggregated less in the presence than in the 
absence of either nonlipolyzed or bcSMase-treated lipid 
 Fig.  2. Aggregation of bcSMase-treated lipid microemulsions. A: 
Lipid microemulsions were treated with 200 mU/ml of bcSMase 
for 30 min, after which lipolysis was stopped, and the bcSMase-
treated lipid microemulsions were incubated at pH 5.5 or pH 7.5 
overnight. Thereafter the lipolyzed samples and, as a control, un-
treated lipid microemulsions, were subjected to fi eld-fl ow fraction-
ation to determine the size of the particles. Please note that in 
contrast to  Fig. 1 , the scale of the  x axis is linear. B: Radiolabeled 
LDL particles and lipid microemulsions, unmodifi ed or bcSMase-
modifi ed, were incubated together in MES-buffered saline (pH 5.5). 
After an overnight incubation, the samples were centrifuged to 
separate the aggregates formed. The radioactivity of the pellets and 
supernatants was measured. Results shown are mean ± SD values of 
three independent experiments. 
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32–35°C ( 27, 28 ) and at which the core lipids of LDL 
particles are in an ordered state. Here, we fi rst studied 
whether SMase-induced LDL aggregation would occur 
below the transition temperature of LDL particles at 
acidic pH. LDL was fi rst treated with bcSMase at 15°C for 
30 min; lipolysis was then stopped by adding EDTA, and 
the incubation of the prelipolyzed LDL particles was con-
tinued either at 15°C or at 37°C and at neutral or acidic 
pH. The treatment of LDL with bcSMase at 15°C resulted 
in hydrolysis of about 60% of the sphingomyelin mole-
cules and, importantly, both sets of particles were identi-
cally lipolyzed. LDL aggregation was observed only at 
37°C, but not at 15°C at both pH values  ( Figs. 4A, B ). CD 
analysis of the samples revealed that at 15°C, no changes 
in the conformation of apoB-100 occurred at either neu-
tral or acidic pH ( Fig. 4C ). This fi nding indicates that the 
conformational changes in apoB-100 are required for par-
ticle aggregation and implies that changes in LDL lipids 
are responsible for the conformational changes. 
 SMase-induced changes in LDL can be linked with an in-
crease in the surface hydrophobicity of the modifi ed parti-
cles ( 29 ). Hydrophobic interactions between modifi ed LDL 
particles can be blocked by isolated and purifi ed apoA-I and 
by the apoA-I-containing HDL 3 particles ( 5, 30 ). Here, we 
examined the ability of HDL 3 particles to inhibit SMase-in-
duced aggregation of LDL at acidic pH. Indeed, as shown in 
 Fig. 5 , HDL 3 particles effectively inhibited the aggregation 
of bcSMase-treated LDL particles. 
 To examine the role of apoB-100 in the SMase-
induced LDL aggregation at acidic pH in more detail, we 
decided to block specifi c regions of the peptide with avail-
able antibodies. Importantly, the N- and C-terminal regions 
of apoB-100 have been shown to become more accessible 
to certain monoclonal antibodies after the LDL particles 
have been treated with SMase ( 31 ). Therefore, we next 
tested whether the SMase-induced LDL aggregation would 
be blocked by the two monoclonal antibodies Bsol 14 or 
Bsol 2, which recognize the N- and C-terminal regions of 
apoB-100, respectively. As demonstrated in supplementary 
Fig. III, preincubation of LDL with either of the antibod-
ies failed to prevent and actually enhanced the subsequent 
SMase-induced LDL aggregation. 
 DISCUSSION 
 In the present study, we show that the lower the pH, the 
higher the degree of aggregation of identically lipolyzed 
LDL particles and the greater is the size of the aggregates 
formed. The aggregates formed after SMase treatment in 
vitro had sizes bigger than 1,000 nm at pH   6.0, while the 
average size of the aggregates formed at neutral pH was 
much smaller, i.e., only up to about 200 nm. Interestingly, 
in human atherosclerotic lesions, the ceramide-containing 
 Fig.  3. Changes in the secondary structure of apoB-100 upon 
bcSMase modifi cation of LDL. A: LDL was proteolyzed by 
 -chymotrypsin (1 mg/ml) for 30 min, proteolysis was stopped by the 
addition of PMSF (1 mM), and the preproteolyzed LDL was treated 
with 500 mU/ml of bcSMase for 15 min, after which lipolysis was 
stopped (  -CT + SMase). Native LDL was treated similarly with 
bcSMase for 15 min, and the lipolysis was stopped (SMase). The 
nonproteolyzed and lipolyzed LDL was divided into two aliquots, 
one of which was treated for 30 min with   -chymotrypsin (1 mg/ml), 
after which the proteolysis was stopped as above (SMase +   -CT). 
The pH of the three incubation mixtures was adjusted to pH 5.5, 
and LDL aggregation was followed by measuring the size of the 
particles by DLS of the samples. B: LDL (1 mg/ml) was treated with 
bcSMase for 30 min, at which time aggregation of LDL particles 
was minimal, and lipolysis was stopped. The samples were diluted 
to give a concentration of 50 µg/ml and far-ultraviolet (UV) CD 
spectra were recorded at 37°C using a 0.1 cm quartz cuvette in the 
region of 190–250 nm at acidic and neutral pH. Five spectra for 
each sample were averaged, and blank measurements were sub-
tracted. Data are representative of three independent experiments. 
C: The lipolyzed LDL was further incubated at pH 5.5 for 30 and 
60 min to induce particle aggregation, after which the far-UV CD 
spectra of the samples were recorded. 
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to arise from interactions between these areas ( 3 ). How-
ever, as shown in the present work, at acidic pH, the SMase-
induced particle aggregation is apoB-100-dependent, the 
conformational changes in apoB-100 induced by sphingo-
myelin hydrolysis being pivotal for LDL aggregation. The 
SMase-induced changes in the lipid monolayer of LDL 
particles were found to lead to remarkable changes in the 
conformation of apoB-100, as refl ected by signifi cantly 
decreased   -helical and increased   -sheet content of the 
protein in the SMase-modifi ed particles. Particle aggrega-
tion could be prevented by performing the SMase treat-
ment at a temperature (15°C) at which the conformational 
changes of apoB-100 were prevented. Below the transition 
temperature of LDL particles (32  35°C) ( 27, 28 ), lateral 
diffusion of LDL surface phospholipids is inhibited by the 
ordered core lipids ( 32 ), which can at least partly explain 
the inhibited conformational changes. Lipolysis-induced 
changes in the conformation of apoB-100 have been 
reported to occur also when LDL is modifi ed by phospho-
lipase A 2 ( 33, 34 ). However, although the aggregation of 
SMase-treated LDL increases dramatically at acidic pH, no 
pH-dependent increase in the aggregation of phospholi-
pase A 2 -treated LDL is seen ( 35 ). Thus, the SMase-induced 
changes in the conformation of apoB-100 appear to lead 
to exposure of specifi c regions of the protein that are par-
ticularly prone to join LDL particles together at acidic pH. 
 The water-exposed parts of apoB-100 are accessible for 
proteases, and, accordingly, proteolytic enzymes cleave such 
regions of apoB-100 into fragments, some of which remain 
bound and some of which are released from the proteo-
lyzed particles ( 3 ). Interestingly, we could strongly inhibit 
the SMase-induced LDL aggregation by proteolytic degra-
dation of SMase-treated LDL particles, but only if proteoly-
sis was performed after SMase treatment. Accordingly, if 
proteolysis was performed before SMase treatment, i.e., when 
native LDL particles were proteolyzed, subsequent SMase 
treatment resulted in LDL aggregation. Thus, we can infer 
that the SMase-induced conformational changes in apoB-100 
must have led to exposure of protease-sensitive apoB-100 
segments that are buried in native LDL, and that these newly 
LDL particles have been reported to be present in two dif-
ferent forms: as very large, micron-sized aggregates, and as 
smaller aggregates ( 5 ), so providing support for potential 
in vivo relevance of the present in vitro observations. 
 The long-standing inference has been that ceramide is 
responsible for aggregation of SMase-treated LDL parti-
cles ( 5 ). Indeed, at neutral pH, ceramide has been sug-
gested to generate hydrophobic nanoenvironments on the 
surface of LDL particles, and particle aggregation is thought 
 Fig.  4. Aggregation of LDL at 15°C. LDL particles were incu-
bated at pH 7.5 with 200 mU/ml of bcSMase for 30 min at 15°C. 
After the incubation, the particles were incubated at either 37°C or 
15°C, and particle aggregation was followed by measuring the tur-
bidity of the samples at pH 5.5 (A) or at pH 7.0 (B). The samples 
were diluted to give a concentration of 50 µg/ml, and far-UV CD 
spectra were recorded at 15°C using a 0.1 cm quartz cuvette in the 
region of 190–250 nm at acidic and neutral pH (C). 
 Fig.  5. HDL 3 inhibits bcSMase-induced LDL aggregation. LDL 
was treated with 200 mU/ml of bcSMase, lipolysis was stopped, and 
the pH of the incubation mixture was adjusted to pH 5.5. LDL ag-
gregation in the absence and presence of 100 µg/ml of HDL 3 was 
followed by measuring the turbidity of the samples. 
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In this work, lipoprotein lipase was found to play a purely 
structural role in linking aggregated LDL to the matrix. 
Interestingly, arterial-wall matrix, lipoprotein lipase, and 
SMase have each been shown to contribute to retention of 
apoB-100-containing lipoproteins and atherogenesis in 
vivo ( 6, 42–44 ). 
 The present study shows that acidity dramatically enhances 
the aggregation of SMase-modifi ed LDL particles and leads 
to formation of micron-sized LDL aggregates. In human 
atherogenesis, acidic environments are likely to be found in 
advanced atherosclerotic lesions ( 15 ). Importantly, hypoxic, 
and therefore also acidic, areas are frequently found in the 
deep layers of prelesional arteries, where lipids initially accu-
mulate and where the formation of the extracellular lipid 
core is initiated ( 11, 14 ). Because acidity increases the ability 
of human secretory SMase to hydrolyze LDL ( 9, 10 ), increases 
the binding of LDL to the extracellular matrix proteoglycans 
( 45, 46 ), and, as shown here, enhances the extent of aggrega-
tion of ceramide-enriched LDL, SMase-induced modifi cation 
of LDL is likely to be particularly deleterious in the acidic 
extracellular microenvironments of prelesional arteries and 
atherosclerotic plaques.  
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exposed segments of apoB-100 are crucial for LDL aggre-
gation. These fi ndings illustrate both the importance of 
SMase-induced conformational changes in apoB-100 in 
triggering LDL aggregation and the indispensable role of 
apoB-100 in particle aggregation. Interestingly, plasmin treat-
ment has been shown to disaggregate vortex-aggregated and 
phospholipase C-aggregated LDL particles ( 36 ), a fi nding 
pointing to the possibility that apoB-100 may have a more 
general role in governing LDL aggregation. In fact, it has 
been suggested that the unique susceptibility of apoB-100 
to aggregation may serve as a quality control mechanism 
that blocks the secretion of potentially toxic lipoproteins 
by the liver, but may unfortunately lead to extracellular 
aggregation and retention in the arterial wall ( 25 ). 
 The SMase-induced conformational changes can be 
linked with an increase in the surface hydrophobicity of 
SMase-treated LDL particles, because SMase-treatment 
of LDL, but not of LDL-derived lipid microemulsions, in-
creases the hydrophobicity of the particles ( 29 ). Therefore, 
a likely cause for particle aggregation is interaction between 
hydrophobic areas of the apoB-100 moieties of the particles. 
ApoA-I and HDL particles have been shown to block aggre-
gation mediated by hydrophobic interactions between 
modifi ed LDL particles, and, indeed HDL particles did in-
hibit SMase-induced LDL aggregation at acidic pH. SMase-
induced LDL aggregation was also blocked by the presence 
of LDL-derived lipid microemulsions. Interestingly, emul-
sions have been shown to interact with LDL particles, and 
incubation of LDL together with emulsions can lead to 
transfer of lipids between emulsions and LDL and can even 
lead to fusion of the emulsions with LDL ( 37, 38 ). These 
changes have also been suggested to modify the conforma-
tion of apoB-100 ( 37 ) and could so interfere with SMase-
induced aggregation of LDL particles. 
 We also reasoned that it would be possible to interfere with 
LDL aggregation by using anti-apoB-100 antibodies so as to 
block the critical interactions leading to aggregation of 
SMase-modifi ed LDL particles. Accordingly, the antibodies 
to test this possibility were chosen based on their increased 
immunoreactivity toward SMase-treated LDL ( 31 ). Unex-
pectedly, however, LDL aggregation could not be blocked by 
these antibodies. Because the selected antibodies bind to se-
quences close to the N- and C-termini of apoB-100 ( 39, 40 ), 
this fi nding may indicate that these areas of apoB-100 are not 
responsible for the particle-particle interactions leading to 
SMase-induced LDL aggregation at acidic pH. 
 The extracellular pH of atherosclerotic plaques has 
been shown to be spatially nonuniform: decreased pH 
values are detected in the deep areas of advanced human 
atherosclerotic lesions, whereas subendothelial areas are 
more likely to have a neutral pH ( 15 ). The extracellular 
matrix proteoglycans may also contribute to the generation 
of acidic microenvironments by increasing the concentra-
tion of H + ions near the sulfate and carboxylic acid groups 
of proteoglycan side chains. Thus, SMase-induced LDL 
aggregation may be particularly accelerated in the vicinity 
of proteoglycans. Indeed, a synergistic action of SMase 
and lipoprotein lipase has been shown to lead to exten-
sive LDL aggregation on smooth-muscle cell matrix ( 41 ). 
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